
Perspective Therapeutics, Inc.: shareholders and insiders
Price
$0.75
November 20, 2026Market cap $91M
What Ploutos Investor adds for Perspective Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from FY2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Nov 19, 2026, from their own Form 4 filings.
Bought on the market
$175.4K
5 people
Sold on the market
$1.6M
2 people
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $175.4K by 5 people·sold $1.3M by 2 people
- 2025: no buys, no sales
- 2026: bought $175.4K by 5 people, sold $1.3M by 2 people
- Nov 18, 2026Robert F Williamson IIIDirectorKind
- Nov 17, 2026Robert F Williamson IIIDirectorKind
- Nov 16, 2026Frank MorichDirectorKind
- Nov 12, 2026Frank MorichDirectorKind
- Nov 12, 2026Robert F Williamson IIIDirectorKind
- Nov 12, 2026Robert F Williamson IIIDirectorKind
- Nov 12, 2026Lori A WoodsDirectorKind
- Nov 12, 2026Markus PuhlmannChief Medical OfficerKind
- Nov 11, 2026Markus PuhlmannChief Medical OfficerKind
- Nov 11, 2026Johan M. SpoorChief Executive OfficerKind
- Sep 4, 2026Lantheus Alpha Therapy, LLCKind
- Sep 3, 2026Lantheus Alpha Therapy, LLCKind
- Sep 2, 2026Lantheus Alpha Therapy, LLCKind
- Sep 1, 2026Lantheus Alpha Therapy, LLCKind
- Sep 1, 2026Lantheus Holdings, Inc.Kind
- Aug 31, 2026Lantheus Alpha Therapy, LLCKind
- Aug 31, 2026Lantheus Holdings, Inc.Kind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Robert F Williamson IIIDirector | 15.0K | $0.80 | $12.0K | Form 4 | |
| Nov 17, 2026 | Robert F Williamson IIIDirector | 25.0K | $0.84 | $21.0K | Form 4 | |
| Nov 16, 2026 | Frank MorichDirector | 15.0K | $0.94 | $14.0K | Form 4 | |
| Nov 12, 2026 | Frank MorichDirector | 15.0K | $1.00 | $15.0K | Form 4 | |
| Nov 12, 2026 | Robert F Williamson IIIDirector | 18.6K | $0.84 | $15.6K | Form 4 | |
| Nov 12, 2026 | Robert F Williamson IIIDirector | 6,289 | $0.84 | $5.3K | Form 4 | |
| Nov 12, 2026 | Lori A WoodsDirector | 23.8K | $0.84 | $20.0K | Form 4 | |
| Nov 12, 2026 | Markus PuhlmannChief Medical Officer | 35.0K | $0.84 | $29.6K | Form 4 | |
| Nov 11, 2026 | Markus PuhlmannChief Medical Officer | 6,000 | $0.83 | $5.0K | Form 4 | |
| Nov 11, 2026 | Johan M. SpoorChief Executive Officer | 47.0K | $0.81 | $37.9K | Form 4 | |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 167.1K | $3.15 | $526.1K | Form 4 | |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC | 80.8K | $3.11 | $250.9K | Form 4 | |
| Sep 2, 2026 | Lantheus Alpha Therapy, LLC | 42.1K | $3.11 | $131.2K | Form 4 | |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC | 35.8K | $3.12 | $111.6K | Form 4 | |
| Sep 1, 2026 | Lantheus Holdings, Inc. | 35.8K | $3.12 | $111.6K | Form 4 | |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC | 78.1K | $3.14 | $245.6K | Form 4 | |
| Aug 31, 2026 | Lantheus Holdings, Inc. | 78.1K | $3.14 | $245.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by CATX's officers and directors from 2006 up to November 21, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Commodore Capital LPwith 3 more personsShare of class9.90%
- TCG Crossover GP II, LLCwith 4 more personsShare of class6.90%
- BlackRock, Inc.Share of class6.80%
- Qatar Investment AuthorityShare of class6.20%
- Johnson FrancesShare of class5.90%
- Schultz Michael KShare of class5.90%
- Integrated Core Strategies (US) LLCwith 3 more personsShare of class5.50%
- Avidity Partners Management LPwith 5 more personsShare of class5.30%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Commodore Capital LPwith 3 more persons | 9.90% | 11.94M | Feb 9, 2026 | 13G | |
| TCG Crossover GP II, LLCwith 4 more persons | 6.90% | 7.92M | Feb 6, 2026 | 13G | |
| BlackRock, Inc. | 6.80% | 7.78M | Jul 29, 20262 filings since Apr 27, 2026 | 13G | |
| Qatar Investment Authority | 6.20% | 7.07M | Feb 5, 2026 | 13G | |
| Johnson Frances | 5.90% | 16.78M | Feb 5, 2024 | 13G/A | |
| Schultz Michael K | 5.90% | 16.78M | Feb 5, 2024 | 13G/A | |
| Integrated Core Strategies (US) LLCwith 3 more persons | 5.50% | 6.32M | Aug 13, 20263 filings since Jun 30, 2026 | 13G/A | |
| Avidity Partners Management LPwith 5 more persons | 5.30% | 6.05M | Mar 10, 20262 filings since Feb 14, 2025 | 13G |
Fell to 5% or less (5)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+4.6%
- Millennium Mgmt (Englander)In the quarter+26%
- Point72 (Cohen)In the quarter
- Renaissance TechnologiesIn the quarter+275%
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 3.98M | +4.6% | $11M | 0.01% |
| Millennium Mgmt (Englander) | 6.19M | +26% | $17M | 0.01% |
| Point72 (Cohen) | 21.3K | $100.0K | 0.00% | |
| Renaissance Technologies | 221.6K | +275% | $600.0K | 0.00% |
| AQR Capital | – | – | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 13.8% of its shares outstanding were held short, +0.7% since the report before.
- Shares held short
- 16.68M
- 13.8%
- Since the report before16.57M on Sep 30, 2026
- +0.7%
- 8.9
- 1.87M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 87%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.05M
- Nov 15, 2023: Shares held short 1.93M
- Nov 30, 2023: Shares held short 1.84M
- Dec 15, 2023: Shares held short 1.81M
- Dec 29, 2023: Shares held short 1.93M
- Jan 12, 2024: Shares held short 1.93M
- Jan 31, 2024: Shares held short 2.05M
- Feb 15, 2024: Shares held short 3.01M
- Feb 29, 2024: Shares held short 1.87M
- Mar 15, 2024: Shares held short 1.88M
- Mar 28, 2024: Shares held short 8.09M
- Apr 15, 2024: Shares held short 10.43M
- Apr 30, 2024: Shares held short 13.59M
- May 15, 2024: Shares held short 15.26M
- May 31, 2024: Shares held short 23.44M
- Jun 14, 2024: Shares held short 29.83M
- Jun 28, 2024: Shares held short 4.31M
- Jul 15, 2024: Shares held short 6.63M
- Jul 31, 2024: Shares held short 6.78M
- Aug 15, 2024: Shares held short 6.95M
- Aug 30, 2024: Shares held short 6.42M
- Sep 13, 2024: Shares held short 7.14M
- Sep 30, 2024: Shares held short 9.59M
- Oct 15, 2024: Shares held short 7.88M
- Oct 31, 2024: Shares held short 8.02M
- Nov 15, 2024: Shares held short 8.28M
- Nov 29, 2024: Shares held short 10.45M
- Dec 13, 2024: Shares held short 9.91M
- Dec 31, 2024: Shares held short 8.93M
- Jan 15, 2025: Shares held short 7.63M
- Jan 31, 2025: Shares held short 5.42M
- Feb 14, 2025: Shares held short 5.48M
- Feb 28, 2025: Shares held short 5.91M
- Mar 14, 2025: Shares held short 5.94M
- Mar 31, 2025: Shares held short 5.71M
- Apr 15, 2025: Shares held short 5.02M
- Apr 30, 2025: Shares held short 5.27M
- May 15, 2025: Shares held short 5.65M
- May 30, 2025: Shares held short 5.28M
- Jun 13, 2025: Shares held short 5.62M
- Jun 30, 2025: Shares held short 6.24M
- Jul 15, 2025: Shares held short 6.35M
- Jul 31, 2025: Shares held short 6.50M
- Aug 15, 2025: Shares held short 6.29M
- Aug 29, 2025: Shares held short 6.37M
- Sep 15, 2025: Shares held short 6.67M
- Sep 30, 2025: Shares held short 6.78M
- Oct 15, 2025: Shares held short 6.49M
- Oct 31, 2025: Shares held short 6.58M
- Nov 14, 2025: Shares held short 6.72M
- Nov 28, 2025: Shares held short 7.15M
- Dec 15, 2025: Shares held short 8.54M
- Dec 31, 2025: Shares held short 8.54M
- Jan 15, 2026: Shares held short 8.21M
- Jan 30, 2026: Shares held short 9.54M
- Feb 13, 2026: Shares held short 9.61M
- Feb 27, 2026: Shares held short 9.64M
- Mar 13, 2026: Shares held short 10.09M
- Mar 31, 2026: Shares held short 14.12M
- Apr 15, 2026: Shares held short 13.67M
- Apr 30, 2026: Shares held short 13.00M
- May 15, 2026: Shares held short 12.62M
- May 29, 2026: Shares held short 12.76M
- Jun 15, 2026: Shares held short 13.63M
- Jun 30, 2026: Shares held short 22.72M
- Jul 15, 2026: Shares held short 22.78M
- Jul 31, 2026: Shares held short 23.47M
- Aug 14, 2026: Shares held short 23.04M
- Aug 31, 2026: Shares held short 23.35M
- Sep 15, 2026: Shares held short 22.81M
- Sep 30, 2026: Shares held short 16.57M
- Oct 15, 2026: Shares held short 16.68M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading43.2% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 43.2% of the shares in the reported trades were short sales, against 48.8% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 43.2%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 48.8%
- Change
- -5.6 pts
- Short sales a dayon average, of 2.44M shares
- 1.06M
- More than atof 3,666 US-listed companies, same days
- 27%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 79.2%
- Oct 15, 2026: Short sales 67.8%
- Oct 16, 2026: Short sales 52.8%
- Oct 19, 2026: Short sales 49.9%
- Oct 20, 2026: Short sales 66.6%
- Oct 21, 2026: Short sales 66.1%
- Oct 22, 2026: Short sales 49.2%
- Oct 23, 2026: Short sales 61.3%
- Oct 26, 2026: Short sales 51.1%
- Oct 27, 2026: Short sales 42.4%
- Oct 28, 2026: Short sales 25.7%
- Oct 29, 2026: Short sales 40.4%
- Oct 30, 2026: Short sales 44.2%
- Nov 2, 2026: Short sales 50.5%
- Nov 3, 2026: Short sales 56.2%
- Nov 4, 2026: Short sales 66%
- Nov 5, 2026: Short sales 61.4%
- Nov 6, 2026: Short sales 51.6%
- Nov 9, 2026: Short sales 77.1%
- Nov 10, 2026: Short sales 11.5%
- Nov 11, 2026: Short sales 13.2%
- Nov 12, 2026: Short sales 53.7%
- Nov 13, 2026: Short sales 29.3%
- Nov 16, 2026: Short sales 40%
- Nov 17, 2026: Short sales 59%
- Nov 18, 2026: Short sales 59.8%
- Nov 19, 2026: Short sales 51.6%
- Nov 20, 2026: Short sales 57%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Lantheus Holdings, Inc.TenPercentOwnerDirectly11.52M
- Lantheus Alpha Therapy, LLCTenPercentOwnerDirectly11.27M
- Lori A WoodsDirectorDirectly28.6K
- Robert F Williamson IIIDirectorDirectly173.9K
- Markus PuhlmannChief Medical OfficerDirectly178.5K
- Johan M. SpoorChief Executive OfficerDirectly130.0K
- Jonathan Robert HuntChief Accounting OfficerDirectly59.8K
- Juan GrahamChief Financial OfficerDirectly35.4K
- Frank MorichDirectorDirectly30.0K
- Heidi HensonDirectorDirectly–
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Lantheus Holdings, Inc.TenPercentOwner | 11.52M | – | Sep 2, 2026 | Form 4 |
| Lantheus Alpha Therapy, LLCTenPercentOwner | 11.27M | – | Sep 4, 2026 | Form 4 |
| Lori A WoodsDirector | 28.6K | 183.5K | Nov 12, 2026 | Form 4 |
| Robert F Williamson IIIDirector | 173.9K | 9,864 | Nov 18, 2026 | Form 4 |
| Markus PuhlmannChief Medical Officer | 178.5K | – | Nov 12, 2026 | Form 4 |
| Johan M. SpoorChief Executive Officer | 130.0K | 4,650 | Nov 11, 2026 | Form 4 |
| Jonathan Robert HuntChief Accounting Officer | 59.8K | – | Nov 13, 2025 | Form 4 |
| Juan GrahamChief Financial Officer | 35.4K | – | Mar 28, 2025 | Form 4 |
| Frank MorichDirector | 30.0K | – | Nov 16, 2026 | Form 4 |
| Heidi HensonDirector | – | 26.0K | Dec 4, 2024 | Form 4 |
A lower bound: it counts only the 10 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.13%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.08%
- IWCiShares Micro-Cap ETFWeight in the fund0.08%
- IBBiShares Biotechnology ETFWeight in the fund0.02%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.02%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VHTVanguard Health Care Index FundWeight in the fund0.00%
16 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 105
- Q4 2025: Managers 117
- Q1 2026: Managers 139
- Q2 2026: Managers 132
Institutional investors by quarter
The fund managers holding CATX, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 132 managers held 89.56M shares, worth $305M. During the quarter 24 opened a position, 31 closed one, 57 added and 26 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+78%
- TCG Crossover ManagementIn the quarter
- Commodore CapitalIn the quarter
- Avidity Partners ManagementIn the quarter-48%
- State StreetIn the quarter+93%
- Millennium Mgmt (Englander)In the quarter+21%
- Nantahala Capital ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter+1.3%
- Affinity Asset AdvisorsIn the quarter+33%
- Citadel Advisors (Griffin)In the quarter+6.7%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 9.49M | +78% | $32M |
| TCG Crossover Management | 7.92M | $27M | |
| Commodore Capital | 6.34M | $22M | |
| Avidity Partners Management | 6.30M | -48% | $21M |
| State Street | 6.05M | +93% | $21M |
| Millennium Mgmt (Englander) | 4.91M | +21% | $17M |
| Nantahala Capital Management | 4.65M | $16M | |
| Vanguard Capital Management | 4.44M | +1.3% | $15M |
| Affinity Asset Advisors | 4.21M | +33% | $14M |
| Citadel Advisors (Griffin) | 3.81M | +6.7% | $13M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Perspective Therapeutics's filings show?
Who buys and sells is one part of Perspective Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CATX's insiders bought or sold?
From Sep 2, 2026 to Nov 19, 2026 Perspective Therapeutics's insiders bought $175.4K and sold $1.6M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold CATX?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $17M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.